(MedPage Today) — One in six patients in phase II oncology clinical trials received a treatment that was eventually approved by the FDA, according to a longitudinal study.
In a sample of 400 phase II trials that included 25,000 participants…
Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/114370
Author :
Publish date : 2025-02-25 21:09:08
Copyright for syndicated content belongs to the linked Source.
